Top Markets
#1 GoPlus Security GoPlus Security +45.21%
#2 GAIB AID GAIB AID +24.67%
#3 Tutorial Tutorial +21.29%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.15%
#5 SkyAI SkyAI +17.91%
#6 Status Status +15.68%
#7 Pons Pons +14.26%
#8 Verus Coin Verus Coin +13.11%
#9 Ontology Gas Ontology Gas +10.37%
#10 Talus Network Talus Network +10.37%
Coin of the day
GoPlus Security GoPlus Security
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
Classifica tra le azioni #33745
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
Prezzo delle azioni
$0.11637199
Capitalizzazione di mercato
$7.20M
Variazione (1 giorno)
3.13%
Variazione (1 anno)
171.06%
Paese
AU
Scambia Vectus Biosystems Limited (VBS)

Categoria

Healthcare
EPS per Vectus Biosystems Limited (VBS)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Vectus Biosystems Limited, l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Vectus Biosystems Limited da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE